Medicine and Me: Living with age related macular degeneration

This event has been postponed and is now planned to take place as a webinar on Thursday 22 April 2021. Find out more and book your place here. 

Jointly organised with Action Against Age-related Macular Degeneration (AAAMD) this meeting will hear from people living age-related macular degeneration (AMD) condition and from experts who work with people with AMD. 

AMD is one of the leading causes of blindness in the world. Around 10 million people have late-stage AMD globally. In the UK alone there are more than 685,000 people with significant sight loss as a consequence of late-stage AMD and with an ageing world population, AMD cases are expected to double by 2040. 

We will be joined by a multidisciplinary faculty of speakers, including people with AMD, their carers and relatives, expert clinicians and researchers to review and discuss current and future approaches to diagnosis and treatment of AMD in the light of an increased understanding of the biology, genetics and epidemiology.

What will you learn?

By attending this meeting, you will have the opportunity to:

• Understand the "status quo" about AMD biology: one or many diseases?
• Know about today’s treatments, their benefits and shortcomings
• Know about the potential of addressing AMD at its early or intermediate stages
• Understand the potential through “big data” of early recognition of those at risk from developing AMD
• Understand the need for a new paradigm to address the challenge of AMD in an ageing population

About Medicine and Me

Medicine and Me meetings aim to provide an outline of current best practice and future updates of important conditions and to give direct voice to patients and their carers and enable them to discuss their concerns and reflections on the impact of diagnosis, investigation and management.

Physicians and surgeons and indeed all healthcare professionals continue to learn from and be inspired to greater efforts to improve care by hearing directly from patients.

Join in the conversation online
Follow us on Twitter: @RoySocMed